Celgene Can't Delay Cancer Drug Antitrust Case, Court Told

By Bryan Koenig · March 4, 2022, 7:03 PM EST

Drug payors pressed a New Jersey federal judge Thursday not to let Celgene Corp. and parent Bristol-Myers Squibb Co. "delay justice and perpetuate the illegal conduct" preventing generic competition for two...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login